Canada · Delayed Price · Currency is CAD Saputo Earnings Call Transcripts
Fiscal Year 2027
-
Earnings grew across all sectors, driven by high-protein ingredient demand, operational efficiencies, and disciplined capital allocation. Margin expansion, strong cash generation, and portfolio optimization supported increased shareholder returns and ongoing investments in growth and innovation.
Fiscal Year 2026
-
Fiscal 2026 featured strong earnings growth, margin expansion, and disciplined capital allocation, with strategic investments in core markets and divestitures from non-core assets. Shareholders approved all board proposals, including director elections and executive compensation, while rejecting external proposals by wide margins.
-
Strong operational execution drove margin expansion and cash flow, despite lower revenues from U.S. commodity pricing. Strategic investments and portfolio shifts toward value-added and branded products are supporting growth, with disciplined capital allocation and a robust balance sheet.
-
Q3 fiscal 2026 saw strong margin expansion, robust cash flow, and improved operational efficiency, despite lower revenue from U.S. commodity prices. All segments delivered higher adjusted EBITDA, with Canada and Europe achieving record profitability and strong brand growth.
-
Q2 saw strong margin expansion, robust cash flow, and double-digit adjusted EBITDA growth, driven by commercial execution and efficiency gains. All segments contributed, with Canada and international showing notable strength, and the outlook remains positive for continued margin recovery and cash generation.
-
Record Q1 adjusted EBITDA and strong cash flow were driven by commercial execution and efficiency gains across all regions. Shareholder returns increased via dividends and buybacks, while innovation and cost discipline supported margin expansion.
Fiscal Year 2025
-
Leadership highlighted strong cost savings, operational improvements, and resilience amid global challenges. Strategic focus remains on innovation, digital transformation, and disciplined expansion, with robust governance and stakeholder engagement.
-
Q4 revenue rose 5% to $4.8B, with stable adjusted EBITDA and strong cash flow. Canada and US saw growth, while Argentina faced headwinds from hyperinflation. Operational efficiencies, cost control, and share buybacks support a confident FY26 outlook.
-
The conference highlighted ongoing benefits from U.S. investments, with $100 million targeted by year-end and further gains expected. Global operations are stabilizing, with Australia and Argentina positioned for growth and the U.K. focused on cost reductions. Consumer trends show trading down and increased private label demand.
-
Q3 2025 saw strong revenue and Adjusted EBITDA growth across all sectors, despite market volatility and a significant U.K. impairment charge. Capital allocation shifted to share repurchases, and operational improvements drove margin gains, with positive outlooks for U.S., Canada, and international segments.
-
Q2 saw strong revenue and EBITDA growth in Canada, broad-based cheese gains in the U.S., and ongoing recovery in Europe, while Argentina faced inflation and currency headwinds. The company announced a share buyback program and expects further operational improvements and cost savings in the second half of fiscal 2025.
-
Q1 saw strong revenue and EBITDA growth, driven by operational improvements, supply chain optimization, and favorable market conditions. U.S. and Canada delivered margin gains, while Australia is set for recovery and Argentina faces ongoing margin pressure.
Fiscal Year 2024
-
Leadership transition and completion of major capital projects marked fiscal 2024, with strong cash generation and operational improvements despite commodity volatility. Fiscal 2025 is expected to deliver improved cash flow, margin gains, and reduced leverage, supported by cost savings and network optimization.